Nusano News
Nusano to Present Isotope Production Capabilities and Commercialization Plans at 7th Theranostics World Congress
Nusano will present at the 7th Theranostics World Congress taking place March 22-24, 2024, in Santiago, Chile. Greg Moffitt, Nusano Director of Target Development, will provide an overview of the company’s proprietary radioisotope production platform on Sunday, March 24.
Nusano Names Rohan Jain as Commercial General Manager
VALENCIA, Calif. – Jan. 22, 2024 – Nusano, a physics company transforming the production of medical radioisotopes,...
Nusano to Host December 19 Virtual KOL Event on Emerging Trends in Radiotherapeutics
EVENT REPLAY NOW AVAILABLE Recorded December 19, 2023Press release updated December 14, 2023 to include addition of...
Nusano to Participate in October Investor Conferences
Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October.
Industry News
Welsh Government seeks to create ‘global centre of excellence in nuclear medicine’
The Welsh Government is working to secure a stable supply of medical radioisotopes for United Kingdom citizens for decades to come.
Global radioisotope shortage hits patients in Pennsylvania
Patients in Pennsylvania are notified that some imaging procedures may need to be delayed or rescheduled due to global shortages in medical radioisotopes.
Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals
Nov. 10, 2022 – The unexpected shut down of a nuclear reactor in Belgium is creating issues for patients in Canada...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates